However, DNL is jointly driven by both PP and PC regions, and disruption of insulin signaling in either region can reduce overall hepatic DNL levels and attenuate the risk of high-fat-diet–induced hepatic steatosis (25). This evidence concerns the gene INS and fatty liver disease.